BackSolid Biosciences Overview

Solid Biosciences Current Cash

Track Solid Biosciences's current cash ($160M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$159.39M
↑ 14.73% YoYΔ $20.46M vs prior year quarter

Peer trimmed avg / median

Loading

Solid Biosciences Current Cash History

Loading

Solid Biosciences vs. peers: Current Cash Comparison

Loading

Solid Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Solid Biosciences (SLDB) FAQ

Solid Biosciences (SLDB) currently reports a current cash of $160M as of June 2026. That compares with $140M in the prior-year period — up 14.7% year over year. Use the charts on this page to explore Solid Biosciences's current cash history and peer comparisons.

Solid Biosciences's current cash increased from $140M to $160M — a 14.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Solid Biosciences reported $160M in current cash as of June 2026. That compares with $140M in the prior-year period — up 14.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Solid Biosciences, and consider following SLDB for alerts when major investors trade the stock.

Solid Biosciences is classified in the Healthcare sector. On current cash, it currently shows $160M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLDB with unrelated industries.